TITLE

Growth hormone therapy market favours biobetters over biosimilars

PUB. DATE
March 2015
SOURCE
Express Pharma;3/16/2015, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the increased in the market of growth hormone (GH) drugs biobetters for the treatment of growth hormone deficiency (GHD) over the GH biosimilars in India. It provides the insights of analyst Lakshmi Dharmarajan of consulting firm GlobalData on the clinical advantages and investments of GH biobetters against biosimilars.
ACCESSION #
109038997

 

Share

Other Topics